Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis
Open Access
- 12 March 2024
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 26 (8) , 858-868
Abstract
No abstract availableKeywords
Funding Information
- Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center
- National Cancer Institute
- CPRIT
- Stand Up To Cancer
This publication has 50 references indexed in Scilit:
- Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagersMolecular Therapy-Oncolytics, 2023
- CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?Cancer Immunology, Immunotherapy, 2022
- Generation of CAR T-cells using γ-retroviral vector2021
- Butyrophilin3A proteins and Vγ9Vδ2 T cell activationSeminars in Cell & Developmental Biology, 2018
- Regulation of Cellular Senescence by Polycomb Chromatin Modifiers through Distinct DNA Damage- and Histone Methylation-Dependent PathwaysCell Reports, 2018
- Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor–modified effector cellsCytotherapy, 2018
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsImmunity, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and RetentionImmunity, 2013
- Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and agingGene, 2007